KMO and neoplasm: It is reported that high expression of tumour biomarkers, namely, APOC1, MMP-1, and KMO, leads to poor prognosis in cancer patients or tumourigenesis, which is in line with our findings in MCTVTs and highlights the importance of the overexpression of tumour-related biomarkers resulting from the surrendered immune environment.